Journal for ImmunoTherapy of Cancer (Nov 2021)
737 Inhibition of P21-activated kinase 4 (PAK4) reverts immune exclusion and restores anti-tumor immunity in the tumor microenvironment
- Rajarshi Bhadra,
- Keith Ching,
- Johnni Gullo-Brown,
- Jonathan Heyen,
- Yu 'Jerry' Zhou,
- Gina Chu,
- Eleanore Hendrickson,
- Brandy Chavez,
- Indrawan McAlpine,
- Eugene Rui,
- Shawn Doran,
- Sergei Timofeevski,
- Jennifer Kinong,
- Szu-Yu Tang,
- Jon Oyer,
- Vinayak Rayannavar,
- Andrew Nager,
- Stephanie Shi,
- Christopher Dillon,
- Murali Gururajan
Affiliations
- Rajarshi Bhadra
- Internal Medicine, St Vincent Charity Medical Center, Cleveland, Ohio, USA
- Keith Ching
- Pfizer Cancer Immunology Discovery, Pfizer Inc, San Diego, California, USA
- Johnni Gullo-Brown
- Oncology Discovery, Pfizer Inc, San Diego, California, USA
- Jonathan Heyen
- Drug Safety R&D, Pfizer Inc, San Diego, California, USA
- Yu 'Jerry' Zhou
- Pfizer, San Diego, CA, United States
- Gina Chu
- Pfizer, San Diego, CA, United States
- Eleanore Hendrickson
- Pfizer, San Diego, CA, United States
- Brandy Chavez
- Pfizer, San Diego, CA, United States
- Indrawan McAlpine
- Pfizer, San Diego, CA, United States
- Eugene Rui
- Pfizer, San Diego, CA, United States
- Shawn Doran
- Pfizer, San Diego, CA, United States
- Sergei Timofeevski
- Pfizer, San Diego, CA, United States
- Jennifer Kinong
- Pfizer, San Diego, CA, United States
- Szu-Yu Tang
- Pfizer, San Diego, CA, United States
- Jon Oyer
- Pfizer, San Diego, CA, United States
- Vinayak Rayannavar
- Pfizer, San Diego, CA, United States
- Andrew Nager
- Pfizer, San Diego, CA, United States
- Stephanie Shi
- Pfizer, San Diego, CA, United States
- Christopher Dillon
- Pfizer, San Diego, CA, United States
- Murali Gururajan
- Pfizer, San Diego, CA, United States
- DOI
- https://doi.org/10.1136/jitc-2021-SITC2021.737
- Journal volume & issue
-
Vol. 9,
no. Suppl 2
Abstract
No abstracts available.
